期刊文献+

HPLC法测定复元胶囊三七皂苷R1及淫羊藿苷的含量 被引量:4

Determination of notoginsenoside R1 and icariin in Fuyuan capsule by HPLC
下载PDF
导出
摘要 目的采用HPLC法检测复元胶囊中主要成分三七皂苷R1和淫羊藿苷的含量。方法取3个不同批次复元胶囊各5粒,经溶解、醇提、萃取、过滤等处理后采用HPLC检测其含量,以地高辛为内标,获得药品和内标曲线下面积之比,按照标准曲线计算出三七皂苷R1及淫羊藿苷的含量。结果计算出每粒复元胶囊中三七皂苷R1的含量为12.18 mg/g,淫羊藿苷的含量为54.65 mg/g。结论本实验HPLC方法可行,能准确检测复元胶囊中三七皂苷R1及淫羊藿苷的含量。 Objective To establish an HPLC method for the determination of notoginsenoside R1 and icariin in Fuyuan capsule.Methods 5 capsules from different batches of target medicine were detected by HPLC after dissolution,ethanol extraction,normal butanol extraction and filtration.Digoxin was as a interior label and the ratio of AUC targets/AUC digoxin were gotten.The contents were calculated by standard curve.Results The content of notoginsenoside Rl and icariin were 12.18 mg/g and 54.65 mg/g respectively.Conclusion The HPLC method in the study is feasible and the experiment data of contents are precise.
出处 《实用药物与临床》 CAS 2015年第3期308-310,共3页 Practical Pharmacy and Clinical Remedies
基金 深圳市龙岗区科技局基金课题(YS2012125)
关键词 复元胶囊 三七皂苷R1 淫羊藿苷 含量测定 HPLC Fuyuan capsule Notoginsenoside R1 Icariin Content determination HPLC
  • 相关文献

参考文献5

二级参考文献17

  • 1刘洪,李荣亨.复原胶囊对气虚血瘀证冠心病血液TXB2、6-Keto-PGF1a、NO、ROS的干预作用及相关机制研究[J].中国老年学杂志,2006,26(11):1484-1485. 被引量:9
  • 2国药管理[1999]363号,中药新药研究的技术要求[S]. 被引量:1
  • 3钟玉,李荣亨,周小莉,巫桁锞,周昌渝.复元胶囊对实验性兔骨关节炎白介素1及转化生长因子β2的调节作用[J].重庆医科大学学报,2007,32(8):856-861. 被引量:16
  • 4Bao J P, Chen W P, Feng J, et al. Variation patterns of two deg- radation enzyme systems in articular cartilage in different stages of osteoarthritis: regulation by dehydroepiandrosterone [ J 1. Clin Chim Acta, 2009, 408 (1/2) :1. 被引量:1
  • 5Radha K S, Madhyastha H K, Nakajima Y, et al. Emodin upreg- ulates urokinase plasminogen activator, plasminogen activator in- hibitor-1 and promotes wound healing in human fibroblasts [ J ]. Vascul Pharmacol, 2008, 48 (4/6) : 184. 被引量:1
  • 6Cicek M, Fukuyama R, Cicek M S, et al. BRMS1 contributes to the negative regulation of uPA gene expression through recruitmentof HDAC1 to the NF-kappaB binding site of the uPA promoter[ J]. Clin Exp Metastasis, 2009, 26 (3) : 229. 被引量:1
  • 7Duke P J, Daune E L, Montufor S P. Studies of chondrogenesis inrotating system [J]. J Cell Biochem, 1994, 15 (3) : 1. 被引量:1
  • 8Peter G M, Herman S C. Tumor necrotic factor and epidermal growth factor regulation of eollagenase and stromelysinin adult por- cine articular chondreeytes [J]. Cell Physiol, 1991, 149: 132. 被引量:1
  • 9Grosios K, Wood J, Esser R, et al. Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, FrK787 / ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis [J]. Inflamm Res, 2004, 53(4) : 133. 被引量:1
  • 10徐淑云.药理实验方法学[M].北京:人民卫生出版社,1991.201. 被引量:106

共引文献24

同被引文献48

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部